|
Volumn 45, Issue 1159, 2003, Pages 49-50
|
Enfuvirtide (Fuzeon) for HIV infection
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
PEPTIDE FRAGMENT;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
ECONOMICS;
FEE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
ANTI-HIV AGENTS;
CHILD;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, VIRAL;
FEES, PHARMACEUTICAL;
HIV ENVELOPE PROTEIN GP41;
HIV INFECTIONS;
HUMANS;
PEPTIDE FRAGMENTS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0037928084
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (2)
|
References (0)
|